Sponsored by Businesswire
Miroculus has developed a novel digital microfluidics technology to
automate and miniaturize genomic protocols such as NGS library prep,
synthetic biology, cell editing, and combinatorial chemistry, in a
compact, user-friendly system. Our vision is to make the most complex
protocols easy and accessible to scientists everywhere.
| Company: | Miroculus | ||||
| Headquarters Address: | 458 Brannan St. | ||||
| San Francisco, CA 94107 | |||||
| Main Telephone: | 4152870505 | ||||
| Website: | |||||
| Type of Organization: | Private | ||||
| Industry: | Research & Science | ||||
| Key Executives: | CEO: Alejandro Tocigl | ||||
| CCO: Adam Lowe | |||||
| Public Relations | |||||
| Contact: | Adam Lowe | ||||
| Phone: |
4158672326 |
||||
| Email: | |||||
| Investor Relations | |||||
| Contact: | Alejandro Tocigl | ||||
| Phone: |
4157708089 |
||||
| Email: |
View source version on businesswire.com: https://www.businesswire.com/news/home/20190304005573/en/